跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 123,382 条关于
“recombinant von Willebrand factor”
全部
123,382
临床试验
114,187
药物
2,853
机构
105
资讯
6,237
去年
FDA Expands Vonvendi Approval to Include Pediatric von Willebrand Disease Patients
3年前
Vega Therapeutics' VGA039 Receives FDA Orphan Drug Designation for Von Willebrand Disease
去年
Star Therapeutics' VGA039 Receives FDA Fast Track Designation for Von Willebrand Disease
11个月前
Star Therapeutics Secures $125M Series D to Advance Von Willebrand Disease Drug VGA039 Through Phase 3 Testing
5个月前
Star Therapeutics Receives FDA Rare Pediatric Disease and Breakthrough Therapy Designations for VGA039 in Von Willebrand Disease
11个月前
Star Therapeutics Secures $125 Million Series D to Advance VGA039 Phase 3 Trial for von Willebrand Disease
10个月前
Star Therapeutics Reports Positive Phase 1/2 Data for VGA039 in von Willebrand Disease at ASH 2025
去年
Hemab Therapeutics Advances Bleeding Disorder Pipeline with Promising Clinical Data at ISTH 2025
3个月前
Incyte to Acquire Vega Therapeutics for Up to $2 Billion, Adding Phase 3 Monoclonal Antibody for Von Willebrand Disease
9个月前
Star Therapeutics Reports Promising Phase 1/2 Data for VGA039 in Von Willebrand Disease, Showing 73-100% Reduction in Bleeding Episodes
第 1 页，共 624 页
上一页
下一页
